Small Animal Imaging Core The main goal of this small animal imaging (SAI) core is to support the proposed projects 1 - 4. Specifically, we will establish/develop the required imaging systems and methods so as to critically evaluate the nanoparticles developed in projects 1, 2 and 4 regarding their bio-distribution, half-life, effectiveness of providing imaging contrast, and potential ability to depict molecular events. In addition, imaging methods and image analysis tools focusing on monitoring lesion progression will also be developed. Furthermore, a direct comparison of the image quality between the proposed SAI computed tomography (CT) system in project 3 and a commercially available SAI CT will be conducted in order to provide strategies for the design of the proposed CT system. Currently, the small animal imaging facility at UNC houses a 3T magnetic resonance imaging (MRI) scanner, single photon emission computed tomography (SPECT) system, and in vivo optical imaging system. While these imaging systems are capable of providing high quality small animal images, additional developments specifically to serve the needs of the proposed projects 1 - 4 are needed. To this end, we will purchase and establish a high field SAI MR scanner to provide much higher spatial resolution images and improved sensitivity to iron oxide based contrast agents (proposed in projects 1, 2, and 4) in Aim 1a. A commercially available CT system will be purchased in Aim 1b to provide high quality and stable CT images for longitudinal studies.
Aim 1 c will further establish a web site that manages machine times and accesses to a dedicated PACS system. In contrast, Aim 2 will focus on developing/evaluating the nanoparticles developed in projects 1, 2, and 4 by utilizing MR, SPECT, and Ol (Aim 2a), direct comparing results from project 3 and that obtained from a commercially available CT system (Aim 2b), and developing multi-modality image analysis tools (Aim 2c).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA119343-03
Application #
7550629
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
3
Fiscal Year
2007
Total Cost
$112,953
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Bowerman, Charles J; Byrne, James D; Chu, Kevin S et al. (2017) Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer. Nano Lett 17:242-248
Giovinazzo, Hugh; Kumar, Parag; Sheikh, Arif et al. (2016) Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer. Cancer Chemother Pharmacol 77:565-73
Koh, Ai Leen; Gidcumb, Emily; Zhou, Otto et al. (2016) Oxidation of Carbon Nanotubes in an Ionizing Environment. Nano Lett 16:856-63
Burk, Laurel M; Wang, Ko-Han; Wait, John Matthew et al. (2015) Delayed contrast enhancement imaging of a murine model for ischemia reperfusion with carbon nanotube micro-CT. PLoS One 10:e0115607
Chu, Kevin S; Finniss, Mathew C; Schorzman, Allison N et al. (2014) Particle replication in nonwetting templates nanoparticles with tumor selective alkyl silyl ether docetaxel prodrug reduces toxicity. Nano Lett 14:1472-6
Chhetri, Raghav K; Blackmon, Richard L; Wu, Wei-Chen et al. (2014) Probing biological nanotopology via diffusion of weakly constrained plasmonic nanorods with optical coherence tomography. Proc Natl Acad Sci U S A 111:E4289-97
Song, Gina; Petschauer, Jennifer S; Madden, Andrew J et al. (2014) Nanoparticles and the mononuclear phagocyte system: pharmacokinetics and applications for inflammatory diseases. Curr Rheumatol Rev 10:22-34
Friedman, Adam D; Claypool, Sarah E; Liu, Rihe (2013) The smart targeting of nanoparticles. Curr Pharm Des 19:6315-29
Chu, Kevin S; Schorzman, Allison N; Finniss, Mathew C et al. (2013) Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy. Biomaterials 34:8424-9
Chu, Kevin S; Hasan, Warefta; Rawal, Sumit et al. (2013) Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft. Nanomedicine 9:686-93

Showing the most recent 10 out of 92 publications